SNCE Science 37 Holdings, Inc.

Science 37, Inc. operates as a technology-enabled clinical trial company that engages in the development of networked patient-centric models for clinical research to accelerate biomedical discovery. The company develops NORA (Network Oriented Research Assistant), a cloud-based patient-centric mobile research platform that helps to offers end-to-end networked clinical trial services and allows researchers to communicate with patients and mobile nurses from homes using videos, photographs, and survey forms. It also offers Science 37 Metasite that provides access to patient population for clinical research; and Science 37 Platform for decentralized clinical trials. It serves large pharmaceutical sponsors, device makers, application developers, individual inventors and scientists, universities, startups, and biotech companies. Science 37, Inc. has a strategic collaboration with Otsuka Pharmaceutical Development & Commercialization, Inc. The company was incorporated in 2014 and is based in Los Angeles, California.

$9.90
As of 12/03/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Health Information Services
Index country:  USA
Country of incorporation:  
IPO date:  11/23/2020
Outstanding shares:  10,011,301
Average volume:  134,790
Market cap:   $98,310,976
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.24
PS ratio:   0.00
Return on equity:   -1.04%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy